Back to results
US 2019/0316141 A1Published application
Fad2 performance loci and corresponding target site specific binding proteins capable of inducing targeted breaks
AssigneesDow AgroSciences LLC, Sangamo Therapeutics, Inc.
InventorsW. Michael Ainley, Steven R. Webb, Jayakumar P. Samuel, Dmitry Y. Guschin, Jeffrey C. Miller, Lei Zhang
Life of this patent
Estimating the term…
Abstract
Methods and compositions for gene disruption, gene editing or gene stacking within a FAD2 loci by cleaving, in a site directed manner, a location in a FAD2 gene in a soybean cell, to generate a break in the FAD2 gene and then optionally integrating into the break a nucleic acid molecule of interest is disclosed.
Claims13
A soybean cell comprising a genetically modified FAD2 gene, the FAD2 gene comprising a mutation within any of SEQ ID NO:
- 14 to SEQ ID NO:
- 20 such that expression of the FAD2 is disrupted.
Dependencies are inferred from the claim text.